statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q4 2023 TELA Bio Inc Earnings Call Transcript

Strong and secure, LIQUIFIX is the first approved adhesive-based product to affix mesh without penetrating patient tissueMALVERN, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ...

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX    the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

TELA Bio Inc (TELA) Announces Earnings with Significant Sales Increase and Strategic Product LaunchesRelated Stocks: TELA...

TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023

Recap: TELA Bio Q4 Earnings

TELA Bio GAAP EPS of -$0.53 misses by $0.10, revenue of $17M beats by $0.61M...

TELA Bio GAAP EPS of -$0.53 misses by $0.10, revenue of $17M beats by $0.61M

MALVERN, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

This is a signal that TELA's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

TELA Bio (TELA, $5.51) RSI Indicator left the oversold zone on March 20, 2024

Exclusive agreement provides MIMEDX with rights to commercialize 510(k) cleared, bovine-derived collagen matrix particulate that is indicated for the management of exudating woundsMARIETTA, Ga...

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

TELA Bio to receive at least $8 million and up to $12 million in total considerationMALVERN, Pa., March 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical...

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

Preview: TELA Bio's Earnings

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

Watchers	246
52-Wk Low	$4.23
52-Wk High	$11.26

Volume	202,357.00
52-Wk High	$11.26
52-Wk Low	$4.23

TELA TELA Bio Inc

About

Feed

News

Sentiment

Earnings

Fundamentals